JWCTF Stock JW CAYMAN THERAPEUTICS (JWCTF, $0.39) was a top loser this quarter, falling -40.93%

GET DAILY SIGNALS

Get AI intraday signals

JWCTF - JW CAYMAN THERAPEUTICS CO LTD.

Loading...

Price: $0.39

Daily change: +$0.0273 (+7.53%)

Daily volume: 20K

3-month price change: -$0.2702 (-40.93%)

Capitalization: $145M

Industry: Biotechnology

JW CAYMAN THERAPEUTICS (JWCTF, $0.39) was a top loser over the last three months, falling -4 to $0.39 per share. A.I.dvisor analyzed 751 stocks in the Biotechnology Industry for the 3-month period ending December 19, 2025, and found that of them (5) exhibited an Uptrend while of them (4) demonstrated a Downtrend.

Momentum Indicator for JWCTF turns negative, indicating new downward trend

JWCTF saw its Momentum Indicator move below the 0 level on December 22, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator turned negative. In of the 36 cases, the stock moved further down in the following days. The odds of a decline are at .

Technical Analysis (Indicators)

Bearish Trend Analysis

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where JWCTF's RSI Indicator exited the oversold zone, of 16 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for JWCTF just turned positive on December 19, 2025. Looking at past instances where JWCTF's MACD turned positive, the stock continued to rise in of 25 cases over the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.159) is normal, around the industry mean (26.541). P/E Ratio (0.000) is within average values for comparable stocks, (51.479). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.873). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (5.907) is also within normal values, averaging (311.015).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. JWCTF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. JWCTF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.